Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

Luckily, there are options that specifically target eczema flare-ups and alleviate the symptoms, including shampoos that are ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The approval was based on data from 2 randomized, double-blind, placebo-controlled trials, ARCADIA 1 and ARCADIA 2.

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing ...

A new study finds that that eczema can worsen when air quality drops from good to moderate levels on the Environmental ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary ...